Company chart and information is provided by TradingView based on 15-minute-delayed data.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
| Website: | www.immunovant.com |
| Email: | info@immunovant.com |
| Main Phone: | +1 917 580-3099 |
| Address: | 320 West 37th Street |
| Address 2: | 3rd Floor |
| State: | NY |
| City / Town: | New York |
| Country: | US |
| Postal Code: | 10018 |
| Exchange: | NGS |
| CEO: | Peter Salzmann |
| Employees: | 42 |
| NAICS: | All Other Basic Organic Chemical Manufacturing(325199) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
